---
title: "BMI and Recurrence-Free Survival in Early-Onset Colorectal Cancer: A Cohort Analysis"
id: "medrxiv-3-weighing-the-odds-body-mass-index-and-recurrence-free-survival-in-early-onset"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-weighing-the-odds-body-mass-index-and-recurrence-free-survival-in-early-onset"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1?rss=1"
published_at: "2026-09-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# BMI and Recurrence-Free Survival in Early-Onset Colorectal Cancer: A Cohort Analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-weighing-the-odds-body-mass-index-and-recurrence-free-survival-in-early-onset
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1?rss=1)
- **Published At:** 2026-09-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study evaluated the association between **body mass index (BMI)** at diagnosis and **recurrence-free survival (RFS)** in early-onset colorectal cancer (EOCRC, 30. - In the AOCRC cohort, continuous BMI was not associated with RFS (LRT p=0.15); the spline curve was essentially flat. - An interaction test indicated a significant difference in the BMI–RFS relationship between EOCRC and AOCRC cohorts (LRT p=0.046). - Authors interpret findings as consistent with an **obesity paradox** specific to EOCRC, but note possible explanations include differences in body composition, tumour biology, systemic metabolism, or methodological bias. - Recommendations: future studies should integrate biomarkers and refined body composition measures to clarify mechanisms. - Ethical approvals, informed consent, and data de-identification procedures were reported; no competing interests declared.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=G0an2a7kEUB10TEfqbO2fvj.p3s1oM3pbC.Glg0am4c-1790037524.8449283-1.2.1.1-4AHhRVxKS_h1BtLljvN4mm3cxApWoLX3r7ja0JUqC94WPhP1jInFpRb0cDsdsPgr) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Weighing the Odds: Body Mass Index and Recurrence-Free Survival in Early-Onset Colorectal Cancer [ View ORCID Profile](http://orcid.org/0009-0000-4860-2690)Erik Delryd, [ View ORCID Profile](http://orcid.org/0000-0002-8370-9749)Andy Tran, [ View ORCID Profile](http://orcid.org/0000-0003-1466-1486)Elinor Bexe Lindskog, [ View ORCID Profile](http://orcid.org/0000-0003-0419-1118)David Ljungman doi: https://doi.org/10.64898/2026.09.19.26363465 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Erik Delryd 1 Institute of Clinical Science, Sahlgrenska Academy; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Erik%2BDelryd%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Delryd%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AErik%2BDelryd%2B) * [ORCID record for Erik Delryd](http://orcid.org/0009-0000-4860-2690 "Open in new tab") Andy Tran 2 University of Iowa; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andy%2BTran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tran%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndy%2BTran%2B) * [ORCID record for Andy Tran](http://orcid.org/0000-0002-8370-9749 "Open in new tab") Elinor Bexe Lindskog 3 Institute of Clinical Sciences, Sahlgrenska Academy * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elinor%2BBexe%2BLindskog%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bexe%20Lindskog%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElinor%2BBexe%2BLindskog%2B) * [ORCID record for Elinor Bexe Lindskog](http://orcid.org/0000-0003-1466-1486 "Open in new tab") David Ljungman 3 Institute of Clinical Sciences, Sahlgrenska Academy * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BLjungman%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ljungman%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADavid%2BLjungman%2B) * [ORCID record for David Ljungman](http://orcid.org/0000-0003-0419-1118 "Open in new tab") * For correspondence: david.ljungman@surgery.gu.se * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1304757/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1304757/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1304757/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1304757/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1304757/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Early-Onset Colorectal Cancer (EOCRC, 30. In AOCRC continuous BMI was not associated with RFS (LRT p=0.15) and the spline curve was flat. An interaction analysis showed a significant difference between the cohorts (LRT p=0.046). Conclusion: Continuous BMI was significantly associated with RFS in EOCRC but not in AOCRC suggesting the "obesity paradox" may be specific to EOCRC. This may reflect differences in body composition, tumour biology and systemic metabolism between EOCRC and AOCRC or may be due to methodological biases. Future research should incorporate biomarkers, as well as refined measures of body composition. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was conducted on Swedish patients who had given informed consent. Data were de-identified after collection from electronic health records and stored securely. The study was approved by the Regional Ethical Review Board in Gothenburg, Department 1 Medicine (approval no. 118-15; approved 3 June 2015). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The study was approved by the Regional Ethical Review Board in Gothenburg, Department 1 Medicine (approval no. 118-15; approved 3 June 2015). All participants had provided informed consent. Data were obtained from electronic health records and de-identified after collection. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.19.26363476v1 "Privacy-Aware Distillation of Large Language Models for Enhanced Multimorbidity Scoring")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.19.26363459v1 "Hyperventilation Unmasks Convergent Aperiodic EEG Vulnerability in Seizure Disorder and Schizophrenia") Posted September 21, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/21/2026.09.19.26363465.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.19.26363465v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/21/2026.09.19.26363465.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Weighing the Odds: Body Mass Index and Recurrence-Free Survival in Early-Onset Colorectal Cancer Erik Delryd, Andy Tran, Elinor Bexe Lindskog, David Ljungman medRxiv 2026.09.19.26363465; doi: https://doi.org/10.64898/2026.09.19.26363465 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.19.26363465v1%26text%3DWeighing%2520the%2520Odds%253A%2520Body%2520Mass%2520Index%2520and%2520Recurrence-Free%2520Survival%2520in%2520Early-Onset%2520Colorectal%2520Cancer "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.19.26363465v1%26t%3DWeighing%2520the%2520Odds%253A%2520Body%2520Mass%2520Index%2520and%2520Recurrence-Free%2520Survival%2520in%2520Early-Onset%2520Colorectal%2520Cancer "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.19.26363465v1%26title%3DWeighing%2520the%2520Odds%253A%2520Body%2520Mass%2520Index%2520and%2520Recurrence-Free%2520Survival%2520in%2520Early-Onset%2520Colorectal%2520Cancer%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.19.26363465v1%26title%3DWeighing%2520the%2520Odds%253A%2520Body%2520Mass%2520Index%2520and%2520Recurrence-Free%2520Survival%2520in%2520Early-Onset%2520Colorectal%2520Cancer "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.19.26363465) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.19.26363465v1&count=horizontal&via=&text=Weighing%20the%20Odds%3A%20Body%20Mass%20Index%20and%20Recurrence-Free%20Survival%20in%20Early-Onset%20Colorectal%20Cancer&counturl=www.medrxiv.org/content/10.64898/2026.09.19.26363465v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (619) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (903) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (335) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4834) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (479) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (419) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (651) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1633) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15981) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (33) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1206) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7067) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (734) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1067) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5064) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1438) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1776) * [Hematology](https://www.medrxiv.org/collection/hematology) (587) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1347) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16310) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1177) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (672) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (155) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (727) * [Neurology](https://www.medrxiv.org/collection/neurology) (7302) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1085) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1244) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1006) * [Oncology](https://www.medrxiv.org/collection/oncology) (3620) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1057) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (398) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (458) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (476) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (140) * [Pathology](https://www.medrxiv.org/collection/pathology) (709) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1805) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (739) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (769) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5922) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9774) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2435) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1456) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1250) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (643) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (773) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (581) * [Surgery](https://www.medrxiv.org/collection/surgery) (783) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (305) * [Urology](https://www.medrxiv.org/collection/urology) (293) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for
## Related Clinical Research

- [Age- and sex-specific links between metabolic syndrome and colorectal cancer risk in UK Biobank](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-age-and-sex-dependent-associations-of-metabolic-syndrome-with-colorectal-cancer.md)
- [Low-fat dietary pattern reduced dietary advanced glycation end-products in the Women’s Health Init](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-low-fat-dietary-pattern-and-dietary-advanced-glycation-end-products-intake-a.md)
- [Obesity-associated inflammation and cancer: mechanisms linking adipose immune changes to tumor risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-obesity-associated-inflammation-and-cancer-molecular-mechanisms-evidence-gaps.md)
- [Clozapine: FDA eases monitoring for children with schizophrenia, but clinician fear remains](https://medichelpline.com/clinical-feed/stat-news-2-opinion-the-fda-removed-the-red-tape-around-one-of-the-best-drugs-for-children.md)
- [Matching Loudness of Auditory Verbal Hallucinations to Audio: Feasibility Study in Schizophrenia S](https://medichelpline.com/clinical-feed/medrxiv-5-can-you-hear-what-i-hear-exploring-ability-and-perspective-when-matching.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.